Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Fondaparinux as Postpartum Venous Thromboembolism Prophylaxis

NCT04447378 is registered in ClinicalTrials.gov with National University of Malaysia as lead sponsor.

NCT NCT04447378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04447378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Fondaparinux as Postpartum Venous Thromboembolism Prophylaxis
Lead sponsor
National University of Malaysia
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2017
Completion date
June 1, 2018
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thromboembolism in the puerperium